Interspecies differences in in vitro etoposide plasma protein binding
- PMID: 1958241
- DOI: 10.1016/0006-2952(91)90364-b
Interspecies differences in in vitro etoposide plasma protein binding
Similar articles
-
Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patients.Cancer Res. 1990 Nov 1;50(21):6854-6. Cancer Res. 1990. PMID: 2208152
-
In-vitro plasma protein binding of propafenone and protein profile in eight mammalian species.Res Commun Chem Pathol Pharmacol. 1989 Jun;64(3):435-40. Res Commun Chem Pathol Pharmacol. 1989. PMID: 2781140
-
Factors affecting in vitro protein binding of etoposide in humans.J Pharm Sci. 1992 Mar;81(3):259-64. doi: 10.1002/jps.2600810315. J Pharm Sci. 1992. PMID: 1640365
-
Extent of plasma protein binding of amphetamine in different species.Biochem Pharmacol. 1972 Jul 1;21(13):1813-6. doi: 10.1016/0006-2952(72)90177-3. Biochem Pharmacol. 1972. PMID: 4630398 No abstract available.
-
Pharmacokinetics and metabolism of deflazacort in the rat, dog, monkey and man.Adv Exp Med Biol. 1984;171:9-23. Adv Exp Med Biol. 1984. PMID: 6372406 Review. No abstract available.
Cited by
-
Population Pharmacokinetic Modeling of Etoposide Free Concentrations in Solid Tumor.Pharm Res. 2016 Jul;33(7):1657-70. doi: 10.1007/s11095-016-1906-4. Epub 2016 Apr 11. Pharm Res. 2016. PMID: 27068281
-
Scaling the time-course of myelosuppression from rats to patients with a semi-physiological model.Invest New Drugs. 2010 Dec;28(6):744-53. doi: 10.1007/s10637-009-9308-7. Epub 2009 Aug 27. Invest New Drugs. 2010. PMID: 19711011
-
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma.Sci Rep. 2023 Sep 1;13(1):14360. doi: 10.1038/s41598-023-40751-z. Sci Rep. 2023. PMID: 37658148 Free PMC article.
-
Assessment of toxicokinetics and toxicodynamics following intravenous administration of etoposide phosphate in beagle dogs.Pharm Res. 1995 Jan;12(1):117-23. doi: 10.1023/a:1016203107497. Pharm Res. 1995. PMID: 7724471
-
Use of etoposide in patients with organ dysfunction: pharmacokinetic and pharmacodynamic considerations.Cancer Chemother Pharmacol. 1994;34 Suppl:S76-83. doi: 10.1007/BF00684868. Cancer Chemother Pharmacol. 1994. PMID: 8070032 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources